baber/WOPTO huggingface dataset:
Patent JP-2002515139-A (JP)
IPC: H01L21/77
Filed: 1998-03-09
Abstract: A high performance pixel is described for active matrix electronic displays. The pixel combines a compact, mesa-isolated PMOS access transistor with a novel, area-efficient HV device. The high voltage transistor features a P+ region at each end of the source to effectively eliminate the parasitic sidewall component and raise the nominal threshold voltage. Concurrently, excess well area is eliminated from the PMOS access transistor to minimize device leakage and the undesirable capacitance component. The improved design enhances pixel response, increases operating margins and contrast and may reduce power dissipation in the off-state.
Patent JP-2001518794-A (JP)
Title: ヒトｇｔｐ結合タンパク質
IPC: C12N15/12
Filed: 1998-04-08
Abstract: (57)【要約】
本発明は、ヒトＧＴＰ結合タンパク質（ＨＧＢＰ）及びＨＧＢＰをコードするポリヌクレオチドを提供する。また本発明は、発現ベクター、宿主細胞、アゴニスト、アンチセンス分子、抗体、またはアンタゴニストを提供する。また本発明は、ＨＧＢＰの発現に関連する疾患の治療方法を提供する。
Patent JP-2001518175-A (JP)
Title: 高効率の直接接触型凝縮方法および装置
IPC: F28B3/00
Filed: 1997-09-12
Abstract: (57)【要約】
下方蒸気流チャンバー10および上方蒸気流チャンバー20を有する直接接触型チャンバーであって、前記蒸気チャンバーの各々が複数の冷却パイプ22、24および蒸気−液体接触媒体28、29を含み、複数の隣接したシートを備えてもよく、下方に取り付けられた実質的に直進の蒸気経路が形成された直進接触型チャンバー。前記上方流チャンバーは、第２の冷却剤供給バイプ26および圧力制御バルブ手段を含む。凝縮器は、さらに分離された凝縮物を回収する容器30、32を含む。計算モデルは凝縮器の性能を推論するための計算に用いてもよい。
Patent JP-2000515413-A (JP)
Title: 三次元パズル
IPC: A63F9/00
Filed: 1997-09-17
Abstract: (57)【要約】
想像力の発達と空間知覚のために設計された教育用ゲーム形式の三次元パズル（１）であって、ｎを１より大きい整数として、相互に同様の小キューブ（２）のようなｎ 3 個（ｎ×ｎ×ｎ個）の小片の集合と、一辺がｎ個の小キューブ（２）からなり、前記三次元パズル（１１）の画像を形成する６ｎ個の異なる２次元パズルのために選択された装飾が異なる断片または部分に対応する装飾を有するメインキューブ片を形成するように、前記小キューブ（２）を接合するための接合手段とから構成されている三次元パズル（１）を特徴としている。
Patent JP-2002500784-A (JP)
Title: 高屈折率かつ高アッベ数の透明有機ポリマー材料からなる光学レンズ
IPC: C08G75/04
Filed: 1999-03-29
Abstract: (57)【要約】
本発明は高屈折率で高アッベ数の透明有機ポリマーからなる眼科用レンズに関する。レンズを形成する材料は、少なくとも１のポリチオールモノマーと、環内にエチレン性二重結合を有するか、環炭素に結合したビニル基またはエチリデン基を有する架橋環末端基を２〜４個含有し、高いアッベ数を示すモノマーの少なくとも１つからなるモノマー混合物の重合によって得られる。本発明は眼鏡レンズ用として好適である。
Patent JP-2002505800-A (JP)
Title: 電子銃を検査するための方法及び装置
IPC: H01J9/18
Filed: 1999-04-01
Abstract: (57)【要約】
電子銃用の電極の組立品が検査される。多数の開口部（少なくとも３個であるが好適には４個）の相対位置が、一方は電極の２個の開口部、例えばＧ１電極及びＧ２電極の位置を決定するため、他方はその他の１個又は複数個の開口部の位置を決定するための、２個の光学システムによって決定される。
Patent MX-158748-A (MX)
Inventor: POUNDER EDWIN
IPC: G01F1/06
Filed: 1983-02-10
Abstract: A fluid flow meter having a paddle wheel rotatably mounted in a cylindrical cavity and an inlet conduit and an outlet conduit tangentially aligned with the periphery of the cavity for directing a fluid to flow through it. The paddle wheel's axis of rotation is displaced from the cavity's centerline, in the direction of the inlet conduit and substantially perpendicular to the flow of fluid entering the cavity, such that the flow meter operates effectively over an extended range of Reynolds numbers, spanning both turbulent and laminar flows.
Patent NZ-183401-A (NZ)
Title: Wood polymer composite containing dicyclopentenyl (4,7-methanoindenyl)-(meth) acrylate
Inventor: BROWN F
IPC: C08L97/02
Filed: 1977-02-21
Abstract: A wood-polymer composite is prepared by impregnating a wood substrate with a liquid dicyclopentenyl acrylate or methacrylate monomer of the formula   <IMAGE>   wherein R is hydrogen or methyl, R' and each R'' are independently hydrogen, chloride or bromide, n is 0 or 1, and the dashed line is an optional chemical bond with the provisoes that when the dashed line is present, n is 0, and when the dashed line is absent, n is 1, and curing the resulting monomer-impregnated wood substrate by either heating same in the presence of a catalytic amount of a thermal initiator, such as a peroxide, or by exposing same to high-energy radiation, such as  gamma -rays. The wood-polymer composite is relatively hard and shows good resistance to hydrocarbon attack.
Patent NZ-192516-A (NZ)
Title: Dispersion of siliceous solid in organic liquid media dental composition
Inventor: NEMCEK J
IPC: A61K6/00
Filed: 1980-01-04
Abstract: Dispersions of colloidal siliceous particles, preferably silica, may be prepared in organic liquids by means of a synergistic mixture of dispersing agents comprising a phosphorus oxy-acid derivatives and a long-chain amine. Dispersions containing a high weight fraction of siliceous solids are possible having a lower viscosity than is normally achieved.
Patent NZ-206109-A (NZ)
Title: A process and composition for the electrodeposition of a coating on a conductive substrate
Inventor: BARLOW A R C
IPC: C09D5/44
Filed: 1983-10-31
Abstract: A conductive substrate as cathode is coated by electrodeposition using a coating material which comprises a sterically stabilised dispersion of film-forming polymer particles in an aqueous medium, the polymer comprising or being associated with a stabilising polymeric non-ionic hydrophilic moiety which is solvated by the aqueous medium and being free from stabilising ionic charges. The dispersion of film-forming polymer particles has a critical coalescence value which is more negative than -0.3 units.
Patent NZ-226993-A (NZ)
Title: Roofing gutter bracket
Inventor: DE WILDE GERRIT JAN
IPC: E04D13/072
Filed: 1988-11-17
Abstract: Bracket unit for fixing a gutter to an eaves section (1), comprising fixing means consisting of a bolt (6) for insertion through a bore formed in the eaves, and mating therewith a nut (4), a bracket part (10; 31; 35, 36), a curved bottom end part of which is suitable for supporting the gutter, and an elongated supporting part (3; 20) with an insertion space (8; 29) for the accommodation and retention therein of the other, top end part (9; 30; 37) of the bracket part (10; 31; 35, 36), a supporting surface to be fitted against a bottom side of the eaves, and a bore (12, 15; 25) for passage of the bolt (6), said bore being directed at right angles to the supporting surface and running through the supporting surface, and also comprising positioning means for positioning the supporting part (3; 20) and the bracket part (10; 31; 35; 36) relative to each other from a number of positions, while the supporting part (3; 20) consists of only one part which is to be fitted on the bottom side of the roof section (1), and the bore (12, 15; 25) of the supporting part (3; 20) has a nut nesting space (12; 26) with limitations which are capable of retaining the nut (4) in the nesting space (12; 26) in such a way that it cannot be turned or lost.
Patent NZ-227797-A (NZ)
Title: Prosthesis for joining hollow tubular organ parts or systems
Inventor: SKEIE EINAR
IPC: A61L31/00
Filed: 1989-01-30
Abstract: A prosthesis for use in joining hollow, e.g. tubular, organ parts or systems, said prosthesis comprising a fragmentable body defining outer organ-supporting surface parts thereon adapted to be arranged in abutting relationship with inner surface parts of the organs to be joined, said body having a compressive strength sufficiently low to allow fragmentation of the body by application of a pressure to the outer surface of the tubular organs subsequently to the joining of the same, said pressure being below a pressure causing any substantial lesion of the tissue of the tubular organ parts. The material of the prosthesis is preferably one or more degradable and/or erodable and/or water-soluble, essentially non-toxic materials which are solid at a temperature of 40 DEG C or higher, in particular 60 DEG C or higher, the material preferably being a polyether, more preferably a polyglycol, in particular polyethylene glycol such as polyethylene glycol with an average molecular weight of from 10,000 to 35,000, especially about 20,000. As shown in Fig. 3, the prosthesis (1) may have tapered outer ends (3) as well as an intermediary portion (4) between the organ-supporting parts and having a smaller diameter. In another embodiment as shown in Fig. 9 or Fig. 13, the end portions may consist of longitudinally and inwardly radially extending fins (11) to give the prosthesis tapering end portions. In a further embodiment, the prosthesis may be a section of tubing with ends cut at an oblique or right angle.
Patent NZ-235300-A (NZ)
Title: Ophthalmic formulations containing a (substituted)phenylalkyl imidazolium salt as a preservative
Inventor: JANSSEN HERWIG
IPC: A61K47/22
Filed: 1990-09-13
Abstract: An ophthalmic formulation comprising a salt of sepazonium or a similar imidazolium compound as a preservative is provided.
Patent NZ-243370-A (NZ)
Title: Sustained release particles containing androgenic steroid dispersed in a biocompatible binder; formulation thereof
Inventor: LABRIE FERNAND
IPC: A61K/
Filed: 1992-06-29
Abstract: Methods of treatment and prevention of estrogen-related diseases, and of fertility control, include low dose (e.g. less than 50 nanomolar serum concentration)administration of certain anabolic steroids, progestins and other substantially non-masculinizing androgenic compounds. Sustained release formulations substantially free of organic solvent, and sustained release formulations for maintaining low serum levels of androgen are disclosed.
Patent NZ-244075-A (NZ)
Title: 1h-imidazo-[4,5-c]quinoline derivatives, preparation, intermediates and pharmaceutical compositions thereof
Inventor: GERSTER JOHN FRANKLIN
IPC: C07D401/12
Filed: 1992-08-25
Abstract: 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines, active as immunomodulators and antiviral agents. Also, intermediates in the preparation of such compounds, pharmaceutical compositions, and pharmacological methods of use.
Patent NZ-260158-A (NZ)
Title: N-benzyl piperazine derivatives, preparation and pharmaceutical compositions thereof
Inventor: WIERZBICKI MICHEL
IPC: A61P25/28
Filed: 1994-03-23
Abstract: The N-benzylpiperazine compounds of formula: <IMAGE>  in which R is as defined in the description. These new compounds and their physiologically tolerable acid addition salts can be used in therapeutics.
Patent NZ-274316-A (NZ)
Title: Yarn positioning apparatus for automated seaming machine
Inventor: KUSTER HEINZ
IPC: D03D41/00
Filed: 1994-09-08
Abstract: A yarn positioning apparatus for use in an automated seaming machine for forming a woven join between opposite ends of a length of woven fabric, of the type in which an auxiliary strip of threads are supported in parallel relation to the cross machine direction threads in the woven fabric. The opposite ends of the fabric are supported on opposite sides of the auxiliary threads and each end of the woven fabric includes a fringe of machine direction (MD) threads. The MD threads are successively separated from the fringe and interwoven with the auxiliary thread to form the join. The yarn positioning apparatus is comprised of a yarn gripper for gripping a previously woven yarn from a fabric fringe in a first orientation and repositioning it to a second orientation. The yarn is retained in its second orientation as it is translated for further processing.
Patent NZ-328190-A (NZ)
Title: Axial piston type internal combustion engine or machine with bevel gears of equal pitch diameter to restrain rotating cylinders relative to reciprocator
Inventor: DUKE NOEL STEPHEN
IPC: F02B75/26
Filed: 1998-06-25
Abstract: Pistons 6 reciprocate in cylinders 12 with piston/cylinder assembly being rotated about axis 1A.  Reciprocator 3 is mounted to rotate relative to crankshaft 2 so as to allow for reciprocation and rotational movement.  Indexing of the piston/cylinder assembly is provided, typically by bevel gears 22, 23.  In order to provide rotational parity of cylinders and pistons bevel gears 20, 21 of identical pitch diameter (and number of teeth) are provided.  These are respectively fixed to reciprocator 3 and the piston/cylinder assembly.
Patent NZ-330372-A (NZ)
Title: Tyre inflation apparatus with equaliser and regulator, and air source independent of vehicle
Inventor: LORD SIMON HAIMONA
IPC: B60S5/04
Filed: 1998-05-05
Abstract: Air source 2A is connected to pressure regulating unit 2 which supplies compressed air to manifold(s) 3 which are connectable to vehicle tyres via lines 5-12.
Patent NZ-333277-A (NZ)
Title: Polymerization using dithiocarboxylic acid derivatives as chain transfer agents
Inventor: LE TAM PHUONG
IPC: C07C329/00
Filed: 1997-07-03
Abstract: A free radical polymerisation process, selected chain transfer agents employed in the process and polymers made thereby, in which the process comprises preparing polymer of general Formula (A) and Formula (B) comprising contacting: (i) a monomer Q selected from the group CH2=CUV, maleic anhydride, N-alkylmaleimide, N-arylmaleimide, dialkyl fumarate and cyclopolymerizable monomers; (ii) a thiocarbonylthio compound selected from Formula (C) and Formula (D) having a chain transfer constant greater than about 0.1; and (iii) free radicals produced from a free radical source; the polymer of Formula (A) being made by contacting (i), (ii) C and (iii) and that of Formula (B) by contacting (i), (ii) D, and (iii); and (iv) controlling the polydispersity of the polymer being formed by varying the ratio of the number of molecules of (ii) to the number of molecules of (iii); wherein R is optionally substituted alkyl, cycloalkyl, aromatic or heteroaromatic ring, alkoxy, dialkylamino, organometallic or a polymer, U is hydrogen, halogen, optionally substituted alkyl, V is hydrogen, R", COOH, COOR", COR", CN, CONH2, CONNR", CONR"2, OOCR" or halogen, Z is hydrogen, chlorine, alkyl, aryl, heterocyclyl, alkylthio, alkoxycarbonyl, aryloxycarbamoyl, cyano, dialkyl- or diaryl-phosphonato, dialkyl- or diaryl-phosphinato or a polymer chain, Z' is a m-valent moiety selected from alkyl, aryl and a polymer chain, m is an integer greater than 2, p and q are integers greater than 1.
Patent NZ-501782-A (NZ)
Title: Package with peelable film layer and peel tab
Inventor: BRADY SEAN A
IPC: B65B61/18
Filed: 1999-12-14
Abstract: This packaging method and apparatus perform the steps of: a. providing a film including a first film component peelably adhered to a second film component; b. providing a support member for supporting a product thereon; c. forming a seal between the second film component and the support member, the seal extending around the product to define a sealed enclosure for the product between the film and the support member; d. Separating the first film component from the second film component within a predetermined region of the film located outside of the sealed enclosure; and e. severing the film within the predetermined, separated region to form an edge on the first film component within the separated region, thereby providing a tab for peeling the first film component from the second film component.
Patent NZ-504579-A (NZ)
Title: Composition containing amine oxide and betaine compounds
Inventor: ABBAS SYED HUSAIN
IPC: C11D1/90
Filed: 1998-11-18
Abstract: A fluid pumpable aqueous composition comprising: i)At least one compound of formula (I), at least one compound of formula (II) and at least one compound of formula (III), with the proviso that this component i) comprises from 36 to 45 weight percent of the composition. In the compounds of formulae (I), (II) and (III): R, R' and R" are independently alkyl, alkenyl or alkyl or alkenylamido alkylene; R1, R2, R3, R4, R5 and R6 are independently alkyl of 1 to 3 carbon atoms; x and y are 0 or 1 with the proviso that x and y can not both be 0 at the same time. ii) An amount of a salt selected from the groups consisting of alkaline earth salts, aluminium salts, or mixtures thereof, sufficient to provide a fluid, pumpable composition. iii) The balance water.
Patent NZ-505995-A (NZ)
Title: Molded frozen bar
Inventor: VAGHELA MADANSINH
IPC: A23G9/20
Filed: 1999-02-18
Abstract: A process for the production of a molded aerated frozen bar which comprises preparing a mix of ingredients suitable for a frozen aerated bar comprising sugar, a corn sweetener and a stabiliser, aging the mix by refrigerated storage at a temperature of from 0°C to 6°C from 1 to 24 hours, whipping the mix at a temperature of from 0°C to 12°C to obtain an aerated mix having an overrun of from 20 to 250 %, filling the mix directly into a mold and quiescently freezing the molded aerated mix.
Patent NZ-507293-A (NZ)
Title: U4, a member of the hematopoietin receptor superfamily
Inventor: DONALDSON DEBRA
IPC: A61P7/06
Filed: 1999-04-09
Abstract: An isolated polynucleotide comprises a nucleotide selected from: a) The nucleotide sequence of SEQ ID NO:4 from nucleotide 242 to nucleotide 1396 b) The nucleotide sequence of SEQ ID NO:6 from nucleotide 71 to nucleotide 1225 c) The nucleotide sequence of SEQ ID NO:9 from nucleotide 136 to nucleotide 1401. An isolated protein comprises the amino acid sequence selected from: a) The amino acid sequence of SEQ ID NO:5 b) The amino acid sequence of SEQ ID NO:7 c) The amino acid sequence of SEQ ID NO:10 Also described are vectors and host cells comprising the nucleotide and pharmaceutical compositions comprising the protein or an antibody that specifically reacts with the protein.
Patent NZ-507980-A (NZ)
Title: Combination therapy for treatment of refractory depression
Inventor: TOLLEFSON GARY DENNIS
IPC: A61K31/445
Filed: 1999-05-21
Abstract: Described is the use of olanzapine in combination with fluoxetine in the preparation of a medicament for attenuating the adverse effects associated with treating a patient suffering from or susceptible to treatment resistant major depression, or partially responding to treatment of major depression, in a patient in need thereof.
Patent NZ-509092-A (NZ)
Title: Ionophore antibiotic formulations containing a dispersing agent with the ionophore antibiotic having a mean particle size of less than 20 microns
Inventor: AGNEW KIM EWING MELVILLE
IPC: A23K20/195
Filed: 2000-12-19
Abstract: An aqueous suspension concentrate ionophore antibiotic composition for use in animal drinking water comprises: at least one ionophore antibiotic of a mean particle size of less than 20 microns; at least one dispersing agent selected from compatible polyglycoside, compatible lignosulphate and compatible and suitable glycol and a gum suspension agent. The composition is capable of dilution with water to a stable and dispersed dilute composition and the dilute form in water remains homogenous for at least 24 days. The suspension agent can be xanthan, guar, acacia or cellulose gum.
Patent NZ-509439-A (NZ)
Title: Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
Inventor: O'BRIEN PATRICK MICHAEL
IPC: C07D307/93
Filed: 1999-06-02
Abstract: Inhibitors of matrix metalloproteinases, eg. gelatinase A (MMP-2), collagenase-3 (MMP-13), and stromelysin-1 (MMP-3). Useful in the treatment of  atherosclerotic plaque rupture, aortic aneurism, heart failure, left ventricular dilation, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound repair, cancer, inflammation, pain, arthritis, osteoporosis, multiple sclerosis, renal disease, and other autoimmune or inflammatory disorders dependent on the tissue invasion of leukocytes or other activated migrating cells.
Patent NZ-517999-A (NZ)
Title: Benzodiazepine derivatives
Inventor: ADAM GEO
IPC: A61K31/5513
Filed: 2000-09-29
Abstract: The present application relates to compounds of general formula (I) wherein X is a single bond or an ethynediyl group, wherein, in the case where X is a single bond, R1 is halogen or phenyl which is optionally substituted with halogen, lower alkyl, halo-lower alkyl, lower alkoxy, halo-lower alkoxy, or cyano; In the case where X is an ethynediyl group, R1 is phenyl, optionally substituted with halogen, lower alkyl, halo-lower alkyl, lower cycloalkyl, lower alkoxy or halo-lower alkoxy; R3 is a 5 or 6 membered aryl or heteroaryl which are optionally substituted. The compounds according to the present invention can be used for treating or preventing acute and/or chronic neurological disorders such as psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits.
Patent NZ-523505-A (NZ)
Title: Composition containing ceramic calcium phosphate particles for skin application
Inventor: MANSOURI ZAHRA
IPC: A61L15/00
Filed: 1996-06-13
Abstract: Active materials such as herbal extracts, allantoin, citric acid, vitamins, anti-inflammatory agents, sun blocking agents, emollients or antimicrobial agents are delivered to the skin of a subject in a composition comprising ceramic calcium phosphate particles, such as ceramic hydroxyapatite in a vehicle for topical application.
Patent NZ-525190-A (NZ)
Title: A kit that detects directly the pathogenicity of the pathogenic influenza A subtype H5 virus
Inventor: YU ALBERT CHEUNG HOI
IPC: C12N15/09
Filed: 2001-09-27
Abstract: Current methods for detecting influenza A subtype H5 virus, for example cell culture, haemagglutination- inhibition, fluorescent antibody and enzyme immunoassay, and reverse transcriptase polymerase chain reaction (RT- PCR) may have the disadvantages of low sensitivity and low specificity. Furthermore, such methods are relatively difficult to use, and may not be suitable for routine detection on a daily basis. A kit for detecting H5 virus is described. The kit provides a user-friendly alternative that is relatively more sensitive and specific to H5 virus. The kit utilizes two specifically designed primers A and B for the replication of H5 virus, and a specific capture probe for immobilizing the amplified viral RNA. An additional primer C is also designed for the detection of pathogenic H5 virus. The detection of H5 virus by the detection kit may be accomplished within one day.
Patent NZ-527683-A (NZ)
Title: A cell therapy method comprising a non-naturally occurring antigen-presenting cell line (nnAPC) that can present up to 15 different peptides simultaneously
Inventor: DEGRAW JULI
IPC: A61K38/21
Filed: 2002-02-19
Abstract: T cell responses are often diminished in humans who have a compromised immune system. A method has been developed to isolate, stimulate and expand naïve cytotoxic T lymphocyte precursors (CTLp) to antigen-specific effectors, capable of lysing tumour cells in vivo. This ex vivo protocol produces fully functional effectors. Artificial antigen presenting cells (AAPCs; Drosophila melanogaster) transfected with human HLA class I and defined accessory molecules, are used to stimulate CD8+ T cells from both normal donors and cancer patients. The class I molecules expressed to a high density on the surface of the Drosophila cells are empty, allowing for efficient loading of multiple peptides that results in the generation of polyclonal responses recognising tumour cells endogenously expressing the specific peptides. The responses generated are robust, antigen-specific and reproducible if the peptide epitope is a defined immunogen. This artificial antigen expression system can be adapted to treat most cancers in a significant majority of cases.
Patent NZ-527704-A (NZ)
Title: A new diffuser in central air conditioning system
Inventor: MHATRE RAMESH NANA
IPC: F24F13/062
Filed: 2002-02-28
Abstract: A diffuser (27) for a central air conditioning system comprising at least a single piece centre core (30), at least one intermediate core (29) and an outer frame (28), the single piece centre core consisting of an outwardly and downwardly directed slanting wall (35) originating from a centre point and ending at a lower peripheral edge area, the wall having smooth inner or lower and outer or upper surfaces, the intermediate core having outwardly and downwardly directed slanting wall portions, the central and intermediate core elements configured so that they may be assembled in nested relationship with the respective walls of central and intermediate core elements adjacent to and spaced from each other.